𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of amiridine and tacrine, drugs effective in Alzheimer's disease, on monoamine oxidase A and B activity

✍ Scribed by Yu. V. Burov; T. D. Baimanov; L. V. Tat'yanenko; N. M. Sokolova; I. M. Tereshchenkova

Publisher
Springer US
Year
1992
Tongue
English
Weight
196 KB
Volume
113
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effect of tacrine and lecithin in Al
The effect of tacrine and lecithin in Alzheimer's disease
✍ K. Peace; N. H. G. Holford πŸ“‚ Article πŸ“… 1994 πŸ› Springer 🌐 English βš– 602 KB

Tacrine, a cholinesterase inhibitor, has beneficial effects on cognition and global status in patients with Alzheimer's disease. These effects have been demonstrated in clinical trials by double-blind comparisons with placebo. Tacrine dosages have been studied in 5 protocols that used either enrichm

A dose-ranging study of selegiline in pa
A dose-ranging study of selegiline in patients with Parkinson's disease: Effect on platelet monoamine oxidase activity
✍ Nathalie Andreu; Christine Damase-Michel; Jean-Michel Senard; Olivier Rascol; Pr πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 337 KB πŸ‘ 1 views

## Abstract A dose‐ranging study of selegiline was performed in patients with Parkinson's disease to determine the minimal dosage of the drug able to inhibit β‰₯95% of platelet monoamine oxidase (MAO) activity. Different doses of selegiline (5 or 10 mg daily, 10 or 20 mg weekly) were studied in four